Enjoy complimentary customisation on priority with our Enterprise License!
The Global Plethysmograph Market size is estimated to grow by USD 18.19 million between 2022 and 2027 accelerating at a CAGR of 3.31%. Factors driving the market growth includes increasing incidence and prevalence of lung and vascular diseases, high demand for advanced diagnostic devices, and increasing awareness about plethysmographs.
This report extensively covers market segmentation by end-user (hospitals, clinics, and others), application (adult and baby), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges.
To learn more about this report, Request Free Sample
Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The increasing incidence and prevalence of lung and vascular diseases are notably driving the market growth. Lung and vascular diseases are the leading causes of mortality and morbidity globally. The incidence and prevalence of vascular diseases, such as DVT and pulmonary embolism (blood clots), and lung diseases, such as asthma and COPD, are increasing globally. These diseases are caused due to the abnormal condition of the arterial blood vessel, which can be diagnosed by using plethysmographs. These factors are increasing their applications globally.
The number of people with lung and vascular diseases is increasing, owing to factors such as sedentary lifestyles, obesity, smoking, environmental issues, lack of physical activity, alcohol consumption, and unhealthy eating habits. The increasing incidence of lung and vascular diseases necessitates the need for early diagnosis and regular monitoring of patients for identifying, treating, controlling, and limiting disease incidence and prevalence rates. The availability of advanced diagnostic devices, such as plethysmograph (which screens arterial and venous pathologies by measuring air and blood volume rates), will drive the market during the forecast period.
The advent of next-generation plethysmographs is the key trend in the market. Manufacturers are focusing on the development of next-generation plethysmographs to avoid misinterpretation of test results caused due to the use of conventional plethysmographs. The next-generation plethysmographs come up with the latest hardware design and advanced software features to provide highly accurate results.
For instance, MiniBox plus by PulmOne Advanced Medical Devices is a technologically breakthrough device with the transformation from a body box lung plethysmograph into an accurate tabletop device. It is a desktop, gasless device with complete PFT, such as whole-body plethysmograph, spirometry, and diffusion testing, used in clinical settings. This device is used to measure TLC, residual volume (RV), and single-breath CO diffusion in less than 2 minutes by providing accurate and repeatable results. Similarly, Q-Box by COSMED is a next-generation body box used for thoracic gas volume measurements, including static lung volumes (TLC, RV, and ITGV) and airway resistance and conductance (RAW and GAW) using a body plethysmograph.
Limitations and complications associated with plethysmographs is the major challenge impeding market growth. A plethysmograph is only used to measure the medical condition of a person with lung and vascular diseases, such as the pain in the chest wall and its muscles and the inability of the lungs to expand or contract, causing difficulty in breathing. It is not suitable to determine the cause of lung or vascular disease. Furthermore, the movement of the patient while using a body plethysmograph for the diagnosis of lungs and the presence of compressible material, particularly chairs with foam padding, within the plethysmography chambers cause unpredictable errors in results.
One of the complications associated with the use of a plethysmograph is an arterial puncture, which includes thrombosis, artery spasm, bleeding, or hematoma. Furthermore, patients may experience claustrophobia, shortness of breath, anxiety, lightheadedness, and infection risks (infection transmission occurs if the device's mouthpiece is not cleaned properly) while performing the test. All these limitations and complications of plethysmographs are expected to have an adverse impact on the market during the forecast period.
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Plethysmograph Market Customer Landscape
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Shanghai TOW Intelligent Technology Co. Ltd. - The company focuses on research, development, and manufacturing of laboratory equipment related to pre-clinical animal and cellular experiments. The company offers plethysmograph namely vivoFlow as its key offering.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
The market share growth of the hospitals segment will be significant during the forecast period. Hospitals are specialized healthcare institutions that offer substantial diagnosis and treatment to patients with acute and complex medical conditions. They have diagnostic centers with expert technicians and sophisticated diagnostic equipment to provide timely, high-quality diagnostic care to patients.
Get a glance at the market contribution of various segments Request a PDF Sample
The hospitals segment was valued at USD 39.41 million in 2017 and continued to grow until 2021. Hospitals account for a significant share of the global plethysmograph market, owing to factors such as the increasing prevalence of acute and chronic diseases and a rise in the number of highly skilled and experienced pulmonologists. Government initiatives, such as the National Health Mission (NHM), to provide free diagnostic services in hospitals with low-cost and non-invasive devices to improve clinical outcomes in patients are also contributing to the growth of the hospitals segment.
For more insights on the market share of various regions Request PDF Sample now!
North America is estimated to contribute 35% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The US is the major revenue contributor to the market in North America, owing to the increasing incidence of lung diseases such as asthma and chronic obstructive pulmonary disease (COPD) and increased research and funding activities. Factors such as the development of next-generation plethysmographs, such as Q-Box by COSMED, will drive the market in the US during the forecast period. Moreover, the presence of key vendors will also drive the growth of the market in the country.
In 2020, the demand for plethysmographs increased rapidly, owing to the rise in the number of COVID-19 cases across North America. Additionally, healthcare spending and the geriatric population in the region are expected to grow significantly during the forecast period. For instance, according to the Population Reference Bureau (PRB), by 2060, the number of Americans 65 years and older is anticipated to nearly double, rising from 52 million people in 2018 to 95 million by 2060. Such factors are expected to drive the growth of the market in North America during the forecast period.
The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
The reports categorize the global plethysmograph market as a part of the global healthcare equipment market. The parent global healthcare equipment market covers products and companies engaged in research and development (R&D) of a variety of product categories, including capital equipment, instruments, implants, accessories, and consumables that are used for the diagnosis, monitoring, and treatment of various diseases. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.
Plethysmograph Market Scope |
|
Report Coverage |
Details |
Page number |
157 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 3.31% |
Market growth 2023-2027 |
USD 18.19 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
2.65 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 35% |
Key countries |
US, Canada, Germany, France, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
ACI Medical LLC, BioTekna Srl, Bonther Equipamentos para Ensino e Pesquisa, COSMED Srl, D. E. Hokanson Inc., Geratherm Medical AG, medical equipment europe GmbH, Medizinische Messtechnik GmbH, MGC Diagnostics Corp., Morgan Scientific Inc., Piston Ltd., PulmOne Advanced Medical Devices Ltd., SCHILLER AG, SCIREQ Scientific Respiratory Equipment Inc., Shanghai TOW Intelligent Technology Co. Ltd., Vyaire Medical Inc., and Medical Electronic Construction |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.